IMPROVING THE COMPREHENSIVE DIAGNOSIS OF NEUROLOGICAL AND PSYCHOEMOTIONAL DISORDERS IN TEMPOROMANDIBULAR JOINT DYSFUNCTION AND TREATMENT BASED ON A NEUROLOGICAL APPROACH
Keywords:
temporomandibular joint dysfunction, neurological disorders, tension-type cephalalgia, psychoemotional state, autonomic dysfunction, complex treatment, neurological approachAbstract
This study investigated the characteristics of the clinical-neurological symptom complex, the interrelationship between autonomic and psychoemotional disorders, and the efficacy of complex therapy based on a neurological approach in 40 patients with temporomandibular joint dysfunction (TMJD). All patients underwent detailed neurological, autonomic, and psychometric examination by a neurologist. The study results demonstrated that tension-type headache (95%), dizziness (70%), paresthesias in the facial area (55%), and autonomic dysfunction syndrome (90%) are the leading neurological syndromes in TMJD. A strong positive correlation was found between pain intensity and levels of anxiety (r=0.72) and depression (r=0.65). The developed differential neurological therapy algorithm (neurometabolic agents, autonomic correction, cognitive-behavioral therapy, and post-isometric relaxation) demonstrated statistically significant higher efficacy compared to the control group receiving only dental treatment, reducing pain syndrome by 2.1 points (p<0.001), decreasing anxiety levels by 32% (p<0.01), and restoring autonomic balance.
References
De Leeuw R., Klasser G.D. Orofacial Pain: Guidelines for Assessment, Diagnosis, and Management. 7th ed. Chicago: Quintessence Publishing; 2023.
Okeson J.P. Management of Temporomandibular Disorders and Occlusion. 8th ed. St. Louis: Mosby; 2020.
Yakhno N.N., Parfenov V.A. Tension-type headache. Meditsinskiy sovet. 2022; (2): 42–48. (In Russian)
Schiffman E., Ohrbach R., Truelove E. et al. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD). J Oral Facial Pain Headache. 2014; 28(1): 6–27.
Woolf C.J. Central sensitization: Implications for the diagnosis and treatment of pain. Pain. 2011; 152(3 Suppl): 2–15.
Chichorro J.G., Porreca F., Sessle B. Mechanisms of craniofacial pain. Cephalalgia. 2017; 37(7): 613–626.
Reiter S., Eli I., Gavish A., Winocur E. Ethnic differences in psychobehavioral factors in TMD patients. J Orofac Pain. 2006; 20(3): 226–234.
List T., Jensen R.H. Temporomandibular disorders: Old ideas and new concepts. Cephalalgia. 2017; 37(7): 692–704.
Pain syndromes in neurological practice / Ed. A.M. Vein. Moscow: MEDpress; 2001. (In Russian)
Slade G.D., Ohrbach R., Greenspan J.D. et al. Painful Temporomandibular Disorder. J Dent Res. 2016; 95(10): 1084–1092.
Vernon L.F. Craniocervical dysfunction and its relationship to temporomandibular disorders. Cranio. 2019; 37(1): 1–2.
Voronina T.A., Seredenin S.B. Nootropic and neuroprotective agents. Eksperim. i klinich. farmakologiya. 2021; 84(3): 3–11. (In Russian)
Cuciureanu M.D., Vink R. Magnesium and stress. In: Vink R., Nechifor M., editors. Magnesium in the Central Nervous System. Adelaide: University of Adelaide Press; 2011.
Turner J.A., Mancl L., Aaron L.A. Brief cognitive-behavioral therapy for temporomandibular disorder pain: Effects on daily electronic outcome and process measures. Pain. 2005; 117(3): 377–387.
Goldstein D.S. Adrenal responses to stress. Cell Mol Neurobiol. 2021; 41(6): 1097–1111.
